On August 9, 2026, the Investment Committee read one JUP fact sheet and did not converge. Two seats said watch, one said avoid, one said buy. The disagreement is the story, and it is worth reading.
The fact sheet every investor read
| Metric | Value | Source | Date |
|---|---|---|---|
| Price | $0.185 | CoinGecko | August 9, 2026 |
| Market cap | $614.2M | CoinGecko | August 9, 2026 |
| Fully diluted valuation | $1.27B | CoinGecko | August 9, 2026 |
| Annualized fees | $361.0M | DefiLlama | August 9, 2026 |
| Market cap to annualized fees | 1.7x | CoinGecko + DefiLlama | August 9, 2026 |
| TVL | $1.54B | DefiLlama | August 9, 2026 |
| Dilution to max supply | 3.01x | CoinGecko | August 9, 2026 |
| Unlock and vesting schedule | not available | DefiLlama, paywalled | August 9, 2026 |
| Protocol treasury | not available | DefiLlama | August 9, 2026 |
Investor A, the compounding case for Jupiter
Investor A called Jupiter the closest thing in this asset class to a real business. It collects fees, roughly $12.0M in the last 30 days, an annualized run rate near $361M. At a $614M market cap that is 1.7x annualized fees, cheap for a genuinely profitable business.
But A buys owner earnings, not gross protocol fees, and buys with a margin of safety. The sheet gives protocol fees but not how much reaches a JUP holder. Fees net of emissions is the number A needs, and the emissions and unlock schedule is not available. A's 5-to-20-year durability test also does not survive contact with a DEX aggregator, whose advantage can be forked and whose demand rides on speculative volume.
Verdict: Watch. Conviction 5 of 10.
Investor B, the margin of safety case for JUP
Investor B called JUP speculation, not a defensible value investment. The protocol produces substantial fees, but the sheet does not establish that those fees accrue to token holders. More importantly, the treasury and unlock schedule are not available. B's primary reason for avoiding JUP is that neither asset backing nor future dilution can be verified, so intrinsic value and a margin of safety cannot be established.
B was the only seat that refused to price the asset at all. Low fee multiples do not solve the problem when fee accrual, treasury backing, and the timing of dilution are all not available. This may be a good protocol, B said, but it is not a good investment at this price.
Verdict: Avoid. Conviction 9 of 10.
Investor C, the macro case for Jupiter
Investor C saw a genuine tension between a strong fee-generating business and a hostile capital structure. On one side, $361M annualized fees against a $614M market cap, a 1.7x multiple that is rare in this asset class. On the other, only 33% of max supply is circulating, a 3.01x dilution overhang sits over every holder, and the unlock schedule is opaque.
C read the macro too. Aggregate stablecoin supply, the closest proxy for crypto-native money supply, contracted 0.99% over the trailing 30 days. Liquidity is quietly leaving the system, and JUP is a high-beta Solana asset that suffers most when the tide goes out.
Verdict: Watch. Conviction 5 of 10.
Investor D, the growth case for JUP
Investor D called Jupiter a stalwart, an established cash-generating business. With $1.54B in TVL and $361M in annualized fees, D read the 3.5x FDV to annualized fees as a potential mispricing if the fees can be sustained. D's variant perception is that the market is punishing the token for its 3.01x dilution overhang while ignoring the cash flow generation.
D flagged the same blind spot as everyone else: the unlock and vesting schedule is not available. But D weighted the fee engine over the overhang and called the current price appealing on fee multiples.
Verdict: Buy. Conviction 6 of 10.
Where they split
The fault line is the unlock schedule. Investor D weighted the fee engine and discounted the dilution overhang. Investor B discounted the fee engine entirely, because holder accrual, treasury backing, and the timing of dilution were all not available. Investors A and C sat between, wanting the fee multiple but refusing to underwrite a thesis built on a schedule they could not see.
The same sheet, the same numbers, four different weights. That is the point of a committee.
What we take from it
The moment worth teaching is Investor B declining to price the asset. B did not estimate intrinsic value when the inputs were missing. No margin of safety could be verified, so B assigned none and said so plainly. A low fee multiple does not fix a thesis built on data you cannot see. That discipline is the whole exercise.
As of August 10, 2026, BagsCapital manages $0 in assets under management, holds no position in JUP, and has never accepted outside capital.